SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-002039
Filing Date
2019-07-24
Accepted
2019-07-24 16:47:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13D sc13da412042002_07242019.htm SC 13D/A 365258
2 JOINDER AGREEMENT ex991to13da412042002_072419.htm EX-99.1 22661
  Complete submission text file 0000921895-19-002039.txt   389405
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86778 | Film No.: 19971522
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734
Business Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734 5127614500
JFL Capital Management, LLC (Filed by) CIK: 0001687888 (see all company filings)

IRS No.: 472302073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A